Response to Office Action

PTO- 1957

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1957

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 88836223 KINISOQUIN(Standard Characters, see http://uspto.report/TM/88836223/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 005 for PHARMACEUTICAL PREPARATIONS INCLUDING THOSE FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.


Proposed:

Tracked Text Description: PHARMACEUTICAL PREPARATIONS INCLUDING THOSE FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19Class 005 for PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Webpage URL: None Provided
Webpage Date of Access: None Provided


ADDITIONAL STATEMENTS
Translation
The wording KINISOQUIN has no meaning in a foreign language.


The owner's/holder's current attorney information: Victoria D Summerfield. Victoria D Summerfield of PEPPER HAMILTON LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at

      501 GRANT STREET SUITE 300
      PITTSBURGH, Pennsylvania 15219
      United States
      The phone number is 412-454-5033.
      The fax number is 8665413889.
      The email address is summerfv@pepperlaw.com

The owner's/holder's proposed attorney information: Victoria D Summerfield. Victoria D Summerfield of Troutman Pepper Hamilton Sanders LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at

      501 Grant Street, Suite 300, Union Trust
      Pittsburgh, Pennsylvania 15219
      United States
The docket/reference number is 148313.50001.
      The phone number is 412-454-5033.
      The fax number is 8665413889.
      The email address is Victoria.Summerfield@troutman.com

Victoria D Summerfield submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.Correspondence Information (current):
      VICTORIA D SUMMERFIELD
      PRIMARY EMAIL FOR CORRESPONDENCE: summerfv@pepperlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): castriom@pepperlaw.com
Correspondence Information (proposed):
      Victoria D Summerfield
      PRIMARY EMAIL FOR CORRESPONDENCE: Victoria.Summerfield@troutman.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): michelle.castriota@troutman.com; docketingpgh@troutman.com

The docket/reference number is 148313.50001.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Response Signature
Signature: /Victoria D. Summerfield/     Date: 01/20/2021
Signatory's Name: Victoria D Summerfield
Signatory's Position: Attorney of Record, PA Bar Member

Signatory's Phone Number: 412-454-5033 Signature method: Sent to third party for signature

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    VICTORIA D SUMMERFIELD
   PEPPER HAMILTON LLP
   
   501 GRANT STREET SUITE 300
   PITTSBURGH, Pennsylvania 15219
Mailing Address:    Victoria D Summerfield
   Troutman Pepper Hamilton Sanders LLP
   501 Grant Street, Suite 300, Union Trust
   Pittsburgh, Pennsylvania 15219
        
Serial Number: 88836223
Internet Transmission Date: Wed Jan 20 15:04:16 ET 2021
TEAS Stamp: USPTO/ROA-XXX.X.XXX.X-202101201504163395
58-88836223-760689ac9e76685b7e7b062b8432
f7127841279687adcedf4b30bc6115508b2e-N/A
-N/A-20210120130349899726